Explore the parallels and differences between AI architectures and the human brain's design and functionality in processing ...

Enterprise AI adoption looks strong, but real ROI lags. Why coordination theater, shadow IT and stalled redesign are distorting compounding value.

Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...

The World Economic Forum's Global Risks Report 2025 identified 7 of the top 10 long-term business risks as ESG-related.

New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients with skin of color expands ...

Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced full-year 2025 financial and operational highlights, including approximately $113 million in net product ...

Q2 2026 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsPaul Hughes - Joint Company SecretarySilviu Itescu ...

The debate surrounding the so-called “new international order” has persisted not because the concept lacks relevance, but because it resists simple definition.

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...

ANKTIVA net product revenue increased 20% quarter-over-quarter, with full-year net product revenue of $113 million, representing an approximately 700% increase year-over-year ...